SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-080794
Filing Date
2023-07-13
Accepted
2023-07-13 17:00:17
Documents
12
Period of Report
2023-07-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2321138d1_8k.htm   iXBRL 8-K 26416
  Complete submission text file 0001104659-23-080794.txt   198335

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fold-20230710.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20230710_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20230710_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2321138d1_8k_htm.xml XML 3208
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 231087300
SIC: 2834 Pharmaceutical Preparations